Haemonetics Corp
HAE75.570USD
+0.800+1.07%
Market hours （ET）Quotes delayed by 15 min
3.64BMarket Cap
21.73P/E TTM
More Details of Haemonetics Corp Company
Haemonetics Corporation is a global healthcare company. The Company is engaged in providing a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. The Company’s technology addresses various medical markets, including blood and plasma component collection, the surgical suite, and hospital transfusion services. The Company’s Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions sold to plasma customers. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. The Company’s Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies, which includes Hemostasis Management, Cell Salvage and Transfusion Management products.
Company Info
Ticker SymbolHAE
Company nameHaemonetics Corp
IPO dateOct 17, 1979
CEOMr. Christopher A. Simon
Number of employees3023
Security typeOrdinary Share
Fiscal year-endOct 17
Address125 Summer Street
CityBOSTON
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code02110
Phone17818487100
Websitehttps://www.haemonetics.com
Ticker SymbolHAE
IPO dateOct 17, 1979
CEOMr. Christopher A. Simon
Company Executives
Name
Name/Position
Position
Shareholding
Change
Ms. Laurie A. Miller
Ms. Laurie A. Miller
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
28.24K
+12.76%
Mr. Charles J. Dockendorff, CPA
Mr. Charles J. Dockendorff, CPA
Independent Director
Independent Director
25.04K
+12.05%
Mr. Robert E. Abernathy
Mr. Robert E. Abernathy
Independent Director
Independent Director
24.98K
+12.08%
Dr. Mark W. Kroll, Ph.D.
Dr. Mark W. Kroll, Ph.D.
Independent Director
Independent Director
23.36K
+13.03%
Ms. Michelle L. Basil, J.D.
Ms. Michelle L. Basil, J.D.
Executive Vice President, General Counsel
Executive Vice President, General Counsel
19.69K
+2.11%
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Chairman of the Board
Independent Chairman of the Board
19.37K
+16.15%
Mr. Michael J. Coyle
Mr. Michael J. Coyle
Independent Director
Independent Director
15.39K
+21.20%
Ms. Diane M. Bryant
Ms. Diane M. Bryant
Independent Director
Independent Director
7.13K
+60.75%
Mr. Roy Galvin
Mr. Roy Galvin
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
3.39K
--
Mr. Frank W. Chan
Mr. Frank W. Chan
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Ms. Laurie A. Miller
Ms. Laurie A. Miller
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
28.24K
+12.76%
Mr. Charles J. Dockendorff, CPA
Mr. Charles J. Dockendorff, CPA
Independent Director
Independent Director
25.04K
+12.05%
Mr. Robert E. Abernathy
Mr. Robert E. Abernathy
Independent Director
Independent Director
24.98K
+12.08%
Dr. Mark W. Kroll, Ph.D.
Dr. Mark W. Kroll, Ph.D.
Independent Director
Independent Director
23.36K
+13.03%
Ms. Michelle L. Basil, J.D.
Ms. Michelle L. Basil, J.D.
Executive Vice President, General Counsel
Executive Vice President, General Counsel
19.69K
+2.11%
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Chairman of the Board
Independent Chairman of the Board
19.37K
+16.15%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
No Data
By RegionUSD
Name
Revenue
Proportion
United States
1.01B
74.29%
Europe
175.66M
12.91%
Asia
92.31M
6.78%
Japan
62.41M
4.59%
other
19.54M
1.44%
By Business
By Region
No Data
Shareholding Stats
Updated: Fri, May 16
Updated: Fri, May 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
11.79%
The Vanguard Group, Inc.
10.59%
Neuberger Berman, LLC
9.05%
Wellington Management Company, LLP
5.46%
T. Rowe Price Investment Management, Inc.
4.57%
Other
58.53%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
11.79%
The Vanguard Group, Inc.
10.59%
Neuberger Berman, LLC
9.05%
Wellington Management Company, LLP
5.46%
T. Rowe Price Investment Management, Inc.
4.57%
Other
58.53%
Shareholder Types
Shareholders
Proportion
Investment Advisor
55.84%
Investment Advisor/Hedge Fund
49.11%
Hedge Fund
4.92%
Research Firm
4.49%
Pension Fund
1.43%
Bank and Trust
1.39%
Individual Investor
1.20%
Sovereign Wealth Fund
0.96%
Venture Capital
0.06%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
697
57.36M
119.41%
-4.15M
2025Q1
723
57.94M
120.44%
-3.07M
2024Q4
701
58.48M
116.40%
-1.44M
2024Q3
689
57.60M
112.60%
-1.51M
2024Q2
668
57.60M
113.31%
+3.07M
2024Q1
655
52.49M
103.35%
-1.26M
2023Q4
647
51.85M
102.19%
-3.31M
2023Q3
657
52.00M
102.54%
-4.11M
2023Q2
656
51.75M
102.38%
-4.68M
2023Q1
715
51.58M
102.24%
-8.44M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
5.67M
11.79%
+31.09K
+0.55%
Mar 31, 2025
The Vanguard Group, Inc.
5.09M
10.59%
-80.50K
-1.56%
Mar 31, 2025
Neuberger Berman, LLC
4.35M
9.05%
-70.98K
-1.61%
Mar 31, 2025
Wellington Management Company, LLP
2.62M
5.46%
-1.32M
-33.38%
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
2.20M
4.57%
-358.25K
-14.03%
Mar 31, 2025
State Street Global Advisors (US)
1.92M
3.99%
-28.97K
-1.49%
Mar 31, 2025
Capital Research Global Investors
1.58M
3.28%
-2.66M
-62.79%
Mar 31, 2025
River Road Asset Management, LLC
1.40M
2.9%
+1.04M
+295.76%
Mar 31, 2025
Thrivent Asset Management, LLC
1.26M
2.63%
+164.11K
+14.92%
Dec 31, 2024
Geode Capital Management, L.L.C.
1.22M
2.54%
+40.32K
+3.41%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
Neuberger Berman Small-Mid Cap ETF
2.26%
SPDR S&P Health Care Equipment ETF
1.9%
Harbor Human Capital Factor US Small Cap ETF
1.81%
Principal U.S. Small-Cap ETF
0.52%
Royce Quant Small-Cap Quality Value ETF
0.42%
Amplify Etho Climate Leadership U.S. ETF
0.35%
Gotham 1000 Value ETF
0.27%
iShares Russell 2000 Growth ETF
0.25%
Inspire Small/Mid Cap ESG ETF
0.23%
Timothy Plan US Small Cap Core ETF
0.23%
View more
Neuberger Berman Small-Mid Cap ETF
Proportion2.26%
SPDR S&P Health Care Equipment ETF
Proportion1.9%
Harbor Human Capital Factor US Small Cap ETF
Proportion1.81%
Principal U.S. Small-Cap ETF
Proportion0.52%
Royce Quant Small-Cap Quality Value ETF
Proportion0.42%
Amplify Etho Climate Leadership U.S. ETF
Proportion0.35%
Gotham 1000 Value ETF
Proportion0.27%
iShares Russell 2000 Growth ETF
Proportion0.25%
Inspire Small/Mid Cap ESG ETF
Proportion0.23%
Timothy Plan US Small Cap Core ETF
Proportion0.23%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
